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Targeted Disruption of TRAF3
Leads to Postnatal Lethality
and Defective T-Dependent Immune Responses
Yang Xu, Genhong Cheng,* and David Baltimore from Fas- or surface IgM–mediated B cell apoptosis
(Gordon, 1995). However, the signal transduction path-Department of Biology
ways from CD40 to these various cellular responses,Massachusetts Institute of Technology
as well as the interrelationships among the individualCambridge, Massachusetts 02139
events, are not clear.
TNF receptor–associated factors (TRAFs) are a novel
family of downstream mediators in the signal transduc-Summary
tion pathway of the TNF receptor superfamily (Hu et al.,
1994; Rothe et al., 1994; Cheng et al., 1995; MosialosTRAF3 was found as a protein that binds to the cyto-
et al., 1995; Sato et al., 1995; Hsu et al., 1996). In theplasmic tail of CD40 but is part of a family of proteins
past two years, at least five members of this family havewith common structure and activity. To clarify the
been identified, TRAF1 through TRAF5 (CD40bp, LAP1,physiological roles of TRAF3, we introduced a TRAF3
CAP1, and CRAF1 were originally used to designatenull mutation in mice through homologous recombina-
the factor now called TRAF3). They all share a well-tion. TRAF3-deficient mice appear normal at birth but
conserved TRAF-C domain in their C-terminus, whichbecome progressively runted, correlating with pro-
is involved in binding to the cytoplasmic tails of TNFgressive hypoglycemia and depletion of peripheral
receptor family members, binding to the intracellularwhite cells. The mutant mice die by 10 days of age.
protein TANK, and heterodimerization or homodimeriza-Fetal liver cells from TRAF3-deficient embryos can
tion among TRAF proteins (Rothe et al., 1994; Cheng etreconstitute all hematopoietic lineages in lethally irra-
al., 1995). In addition, members in this family also containdiated mice. However, these reconstituted mice are
several other distinct functional domains such as ringimpaired in their immune responses to T-dependent
fingers, zinc fingers, isoleucine zippers, and TRAF-Nantigen, and their T cells are functionally defective.
(Rothe et al., 1994; Cheng et al., 1995).These findings indicate that TRAF3 is required for
It seems likely that there are specificities of functionpostnatal development and for a competent immune
among individual TRAF family members, which couldsystem.
be determined by several factors. First, the affinities of
binding to the cytoplasmic tails of TNF receptor family
Introduction members. For instance, TRAF2 binds to the tails of both
CD40 and TNF receptor II (TNFRII) with high affinity,
Tumor necrosis factor (TNF) receptor superfamily mem- while TRAF3 and TRAF5 bind to the tail of CD40 but not
bers, mostly type I transmembrane proteins with a con- that of TNFRII, and TRAF1 does not directly bind to the
served cysteine-rich pseudorepeat in the extracellular tail of either TNF receptor (Rothe et al., 1995). Second,
region, are thought to play important roles in the regula- the patterns of dimerization. TRAF2 and TRAF3 but not
tory events in many different cell lineages, including TRAF1 can form homodimers, while TRAF1 and TRAF2
neural, hematopoietic, and lymphoid (Smith et al., 1994). can also form a heterodimer (Rothe et al., 1994; Cheng
One family member, CD40, is a receptor on the B cell and Baltimore, 1996). Third, different N-terminal func-
surface and interacts with CD40 ligand (CD40L), a type tional domains. Despite the fact that all the TRAF pro-
II transmembrane protein of the TNF family that is mainly teins contain the C-terminal TRAF-C domains, their
expressed on the surface of activated helper T cells N-terminal functional domains are more variable. TRAF1
(Hollenbaugh et al., 1992). Targeted disruption of either does not contain the ring fingers and zinc fingers found
the CD40 or CD40L gene results in viable mice with in TRAF2 and TRAF3. In addition, there are functional
extensive defects in T-dependent antigen responses, differences between the ring finger domains of TRAF2
including immunoglobulin class switching, germinal and TRAF3 in the case of NF-kB activation (Rothe et
center formation, and cell-mediated immunity (Kawabe al., 1995; Cheng and Baltimore, 1996). Fourth, tissue
et al., 1994; Xu et al., 1994; Grewal et al., 1995; van expression pattern. TRAF2 and TRAF3 are ubiquitously
Essen et al., 1995). In addition, mutations in the CD40L expressed (Rothe et al., 1994; Cheng et al., 1995). TRAF1
gene cause X-linked hyper–immunoglobulin M (IgM) is highly expressed in spleen, lung, and testis and TRAF5
syndrome in humans as a result of defective class in spleen, lung, and thymus (Rothe et al., 1994; Nakano
switching (Aruffo et al., 1993). Therefore, the CD40– et al., 1996). TRAF4 is expressed at high levels in several
CD40L interaction is essential for both humoral and cel- breast carcinoma cell lines, but is undetectable in nor-
lular immune responses. Studies using cultured B cells mal tissues (Regnier et al., 1995).Furthermore, individual
further indicate that CD40 mediates many cellular TNF receptor family members may associate with one
events, including up-regulation of cell surface receptors or several different TRAFs, which in turn could form
such as CD23, B7-1, and ICAM-1 and of intracellular different complexes, thus conferring a large spectrum
proteins such as NF-kB and Bcl-X; activation of serine, of specificities to modulate divergent physiological
threonine, and tyrosine phosphorylation; and rescue functions.
TRAF3 was originally isolated using yeast two-hybrid
screening for binding to the cytoplasmic tails of CD40*Present address: Jonsson Comprehensive Cancer Center, Univer-
and the Epstein–Barr virus latent membrane protein,sity of California Los Angeles School of Medicine, 10833 LeConte
Avenue, Los Angeles, California 90095. LMP1 (Hu et al., 1994; Cheng et al., 1995; Mosialos et
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Figure 1. Targeted Disruption of the TRAF3
Gene
(A) Genomic configuration of the germline
TRAF3 locus. Exons are represented with
open boxes, and the initiation ATG is indi-
cated. The lengths of the diagnostic EcoRI
restriction fragment and the probe A are
shown. The transcriptional direction of the
TRAF3 gene is indicated with an arrowhead.
(B) Targeting construct to replace the two ex-
ons with the PGK–neor gene. The transcrip-
tional direction of the PGK–neor gene is indi-
cated with an arrowhead and is opposite that
of the TRAF3 gene.
(C) Targeted locus following homologous re-
combination between the targeting construct
and the endogenous locus. The length of the
EcoRI diagnostic restriction fragment is indi-
cated.
(D) Southern blot analysis of the tail DNA from
TRAF31/1, TRAF31/2, and TRAF32/2 mice.
Tail DNA was digested with EcoRI and hybrid-
ized to probe A. The DNA size marker is
shown on the left.
(E) Western blot analysis of TRAF3 expres-
sion in TRAF2/2 mice. Cell lysates derived
from untreated 293 cells (minus control) or
293 cells transfected with TRAF3 expression
vector (plus control) were used as controls
(Cheng and Baltimore, 1996).
al., 1995; Sato et al., 1995). Subsequently, it has also exons of the gene containing the ATG initiation codon
(Figures 1Aand 1B). To screen for homologous recombi-been shown to be associated with the cytoplasmic tail
of CD30 and lymphotoxin b-receptor (Gedrich et al., nants by Southern blot, genomic DNA isolated from
transfected embryonic stem (ES) cells was digested with1996). The N-terminal truncated TRAF3, when overex-
pressed in human Ramos B cells, inhibits CD40-medi- EcoRI and probed with the probe A located outside of
the targeting construct, givinga 23kb germline bandandated up-regulation of CD23 and B7-1, as well as rescue
of Fas-mediated cell apoptosis (Cheng et al., 1995; un- an 8.5 kb mutant band (Figures 1A–1C). Three TRAF3
heterozygous mutant (TRAF31/2) ES cells injected intopublished data). Since this C-terminal portion of TRAF3
could also prevent binding of other TRAF proteins to blastocysts gave rise to chimeric mice transmitting the
mutation in the germline. TRAF31/2 mice were inter-the CD40 cytoplasmic tail as well as inhibit the functions
of other TRAFs by forming heterodimers with them, it crossed to generate TRAF32/2 mice. Tail DNA isolated
from TRAF31/1, TRAF31/2, and TRAF32/2 mice was ana-is not clear which TRAF family member(s) is interfered
with by the truncated TRAF3. To determine whether lyzed by Southern blot (Figure 1D).
Because TRAF3 is ubiquitously expressed, weTRAF3 has a role in the CD40 signal transduction path-
way, and whether TRAF3 has other functions in vivo, checked levels of the TRAF3 protein in various tissues
of TRAF32/2 mice by affinity purification and subsequentwe have produced mice deficient in TRAF3. TRAF32/2
mice become runted and die about 10 days after birth, Western blot with polyclonal antibody against the
C-terminal portion of TRAF3. No TRAF3 protein couldindicating that TRAF3 has broader roles than that in
CD40 signaling. In addition, while TRAF3 is not required be detected in any tissues of TRAF32/2 mice tested,
indicating that the mutation is a null mutation (Figurefor the development of various hematopoietic lineages,
studies of lethally irradiated mice reconstituted with 1E). Consistent with this finding, no TRAF3 mRNA can
be detected in the total RNA derived from the brain ofTRAF32/2 fetal liver cells indicate that TRAF3 is required
for T-dependent immune responses. TRAF32/2 mice by Northern blot hybridized with a TRAF3
cDNA fragment encoding the C-terminus (data not
shown).Results
Targeted Disruption of TRAF3 Early Postnatal Lethality in TRAF32/2 Mice
While TRAF32/2 mice appeared normal at birth, theyTo create a null TRAF3 mutation in mice, we designed
a targeting construct that would disrupt the first two were obviously smaller than their normal littermates by
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Figure 2. Developmental Defects in TRAF32/2 Mice
(A) TRAF32/2 mice become progressively runted. A 9-day-old TRAF32/2 mouse (right) and a normal littermate (left) are shown.
(B) The cellularity of the spleen is greatly reduced in TRAF32/2 mice. Shown are spleens recovered from 7-day-old TRAF31/1 (top) and TRAF32/2
(bottom) littermates.
(C) Progressive depletion of blood white cells in the TRAF32/2 mice. Percentile ratios of white cell count in TRAF32/2 mice of various ages
versus white cell counts in TRAF31/1 littermates are plotted against the age of the mice.
(D) The glucose level in TRAF32/2 mice is progressively reduced compared with TRAF31/1 littermates. Percentile ratios of blood glucose level
in TRAF32/2 mice of various ages versus that in TRAF31/1 littermates are plotted against the age of the mice.
day 3. The mutant mice become more runted with time, mice at day 7 by flow cytometry. We recovered only a
few percent of the normal number of thymocytes, andand by day 9 their body weights were only about 20%
those of their normal littermates (Figure 2A; data not among these there was a relative reduction of
CD41CD81 double positive thymocytes (Figure 3A). Theshown). Although all TRAF32/2 mice died by day 10,
histological studies of mutant mice have failed to reveal bone marrow showed reduced percentages of
B2201IgM2 B lineage precursor cells and a normal per-any gross defect in the structures of tested organs,
including brain, lung, heart, thymus, liver, kidney, and centage of granulocytic cells (Figure 3B). Although B
and T cell precursors were lower, indicative of reducedspleen (data not shown).
In an attempt to understand the basis of the runting production of lymphoid cells, the continuing production
of B and granulocytic lineage cells in the bone marrowin TRAF32/2 mice, we examined their glucose levels.
Although the TRAF32/2 mice suckled and had milk in of TRAF32/2 mice suggested that the depletion of the
white cells in the periphery was not due to a totaltheir stomachs, they displayed a progressive decrease
of glucose levels, which correlated with the degree of blockage of the differentiation of these hematopoietic
lineages. Therefore, the depletion of peripheral whiterunting (Figure 2D). It is not clear whether this is the
primary cause of runting. cells in TRAF32/2 mice could be due to intrinsic defects
in cell survival or secondary to some physiological
changes, such as up-regulation of cytotoxic factors.Hematopoietic Lineages in TRAF32/2 Mice
The lymphoid organs in TRAF32/2 mice were smaller
than those of normal littermates, and by day 7 after birth Fetal Liver Cells from Day 14 TRAF32/2 Embryos
Can Reconstitute All Hematopoietic Lineagesthe spleen of TRAF32/2 mice was rudimentary, with a
cellularity only about 1% that of normal littermates (Fig- in Lethally Irradiated Mice
To test whether TRAF32/2 white cells are intrinsicallyure 2B). Histologically, however, the structure of the
spleen of TRAF32/2 mice remained intact. We also ob- defective in cell survival, as well as to examine the possi-
bility that the runting in TRAF32/2 mice is caused by aserved a progressive depletion of all lineages of white
cells in the periphery of TRAF32/2 mice (Figure 2C). deregulated hematopoietic system, we transplanted the
day 14 TRAF32/2 fetal liver cells into lethally irradiatedWe examined the hematopoietic lineages in TRAF32/2
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the in vitro responses of TRAF32/2 B cells to anti-IgM
and CD40L. TRAF31/1 and TRAF32/2 resting B cells were
purified from spleens of chimeric mice. All the B lineage
cells in the chimeras were derived from the donor be-
cause they carried the Ly9.1 marker, differentiating them
from the recipient Ly9.21 cells (data not shown; Turner
et al., 1995). We did not observe a consistent difference
in the proliferative responses of TRAF31/1 and TRAF32/2
B cells to increasing concentrations of (Fab9)2 anti-IgM
antibody or membrane-bound CD40L (mCD40L) (Fig-
ures 5A and 5B). Since CD40 transduces signals that up-
regulate B cell surface marker CD23 and B7-1 (Gordon,
1995), we tested the effects of mCD40L on TRAF32/2 B
cells in these activities. TRAF32/2 B cells up-regulated
both B7-1 and CD23 in thepresence of mCD40L (Figures
5C and 5D). Together, these findings suggest that TRAF3
is not required for CD40 signaling.
Immune Responses in TRAF32/2 Chimeric Mice
Because CD40 is involved in T-dependent immune re-
sponses and TRAF3 had been implicated in mediating
CD40 signaling (Cheng et al., 1995; Kawabe et al., 1994),
we examined the immune response of TRAF32/2 chime-
ric mice to T-dependent and T-independent antigens.
The T-dependent immune response to NP15–CG was
defective in TRAF32/2 chimeric mice, but the T-indepen-
dent immune response to NP–Ficoll was normal (Figures
6A and 6B). Together with the finding that TRAF32/2 B
cells proliferate normally in response to stimuli such as
anti-IgM and CD40L, these data suggest that TRAF32/2
B cells may be functionally normal. The defective
Figure 3. Analysis of Hematopoietic Cells in TRAF32/2 Mice T-dependent immune response in TRAF32/2 chimeric
Flow cytometric analysis of hematopoietic cells in the thymus and mice may be due to dysfunctional T cell help.
bone marrow of 7-day-old TRAF32/2 and TRAF31/1 littermates. In
the analysis of thymus and B lineage cells in the bone marrow, cells
Impaired T Cell Functions in TRAF32/2residing in the lymphoid gate were analyzed, and the percentage
Chimeric Miceof total cells in a particular region is indicated.
To test the possibility that TRAF32/2 T cells are intrinsi-
cally defective, mice reconstituted with TRAF31/1 or
TRAF32/2 fetal liver cells were sensitized by injection ofmice. As controls, fetal liver cells from TRAF31/1 em-
ovalbumin, and 14 days later the in vitro proliferativebryos were also transplanted. TRAF32/2 fetal liver cells
responses of cells recovered from the draining lymphcould reconstitute T, B, granulocytic, and erythroid lin-
nodes to ovalbumin were compared. In vivo primedeages, and recipient mice could survive longer than 6
TRAF32/2 T cells were defective in their proliferativemonths (Figures 4A–4C). In addition, the cellularity and
response to antigen, indicating that TRAF32/2 T cells arecomposition of the thymus and spleens of the mice
functionally impaired (Figure 7A). However, TRAF32/2reconstituted with TRAF32/2 fetal liver cells were similar
lymph node T cells proliferated normally in response toto those of mice reconstitutedwith normal fetal liver cells
anti-CD3e antibody, indicating that these T cells are not(data not shown). These findings indicate that TRAF32/2
inert (Figure 7B).cells are not intrinsically prone to die and, therefore,
that the depletion of peripheral white cells in the mutant
mice is more likely due to up-regulation of cytotoxic Discussion
factors. In support of this notion, the level of corticoste-
rone in day 4 and 5 TRAF32/2 mice (average of 2200 mg/l) From the phenotype of TRAF32/2 mice, it is evident that
is much higher than that of normal littermates (average of TRAF3 (originally CRAF1) plays a critical role in at least
97 mg/l). The one defect we observed in the reconstitu- two systems of the body. One is wholly undetermined,
ted mice was a reduction of B lineage precursors in the but leads to neonatal wasting and death correlated with
bone marrow (Figure 4B), suggesting that TRAF3 may a low glucose level, high corticosterone level, and deci-
play some role in B cell development. mation of white blood cells. The other is in the function
of cells involved in T-dependent immune responses.
Much of the latter function might be explained by theIn Vitro Responses of TRAF32/2 B Cells
to Anti-IgM and CD40L need for TRAF3 for a T cell proliferative response to
antigen.Because TRAF3 has been implicated in mediating CD40
signaling, which is involved inB cell activation,we tested TRAF32/2 mice are born apparently normal, indicating
Functional Studies of TRAF3 In Vivo
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Figure 4. Analysis of Hematopoietic Cells in Lethally Irradiated Mice Reconstituted with TRAF32/2 Fetal Liver Cells
Flow cytometric analysis of hematopoietic cells in lethally irradiated mice 2 months after being reconstituted with day 14 fetal liver cells from
either TRAF31/1 or TRAF32/2 embryos. In (A) and (B), cells residing in the lymphoid gate were analyzed and the percentage of total cells in
a particular region is indicated. In (C), total white cells were analyzed and the percentage of positive cells is shown.
that TRAF3 is not required for embryonic development. TRAF3 and CD40 Signaling
Stimulation of B cells with CD40L leads toB cell survival,However, soon after birth, the need for TRAF3 becomes
evident. The symptoms, low glucose, high steroid, and proliferation, and differentiation (Gordon, 1995). Be-
cause overexpression of a truncated TRAF3 (mainly thewhite cell death, could all be responses to some other
defects. It is possible that the low glucose level in the TRAF-C domain) in human B cells disrupted CD40-medi-
ated up-regulation of CD23 and the ability of CD40 tomutant animals is a response to the increased cortico-
steroid. In addition, runting could be due to up-regula- rescue apoptosis, we had suggested that TRAF3 is in-
volved in these processes (Cheng et al., 1995). However,tion of cytotoxic cytokines, such as TNF, produced by a
deregulated hematopoietic system (Probert et al., 1993). TRAF32/2 B cells proliferate and up-regulate CD23 nor-
mally in response to mCD40L stimulation (Figure 4).By reconstituting the hematopoietic system of lethally
irradiated wild-type mice with TRAF32/2 fetal liver cells, Therefore, TRAF3 appears dispensable for CD40-medi-
ated B cell activation and survival in vitro, implying thatwe ruled out the possibility that mutant hematopoietic
cells are causing the runting, because such mice lack overexpression of the TRAF-C domain must disrupt the
functions of other TRAF family members. In support ofany sign of runting. Furthermore, TRAF32/2 mice lack
the histological defects observed in wasted mice with this notion, it is TRAF2 rather than TRAF3 that mediates
the activation of NF-kB through CD40 (Cheng and Balti-a high level of TNF (Probert et al., 1993).
TRAF family members have been implicated as media- more, 1996; Rothe et al., 1995), and TRAF5 has the same
ability (Nakano et al., 1996).tors of signal transduction initiated by the TNF receptor
family, suggesting that they might play important roles While TRAF3 is not required for CD40-mediated B cell
activation in vitro, the immune responses in chimericin a large number of physiological processes, including
cell growth and death (Baker and Reddy, 1996). Consis- mice reconstituted with TRAF32/2 fetal liver cells are
very similar to those in CD402/2 mice. Both are defectivetent with this notion, white cells in the blood, spleen,
and thymus of TRAF32/2 mice are depleted after birth. in T-dependent immune responses but normal in T-inde-
pendent immune responses (Kawabe et al., 1994). InHowever, the loss of white cells appears not to be due
to intrinsic defects in cell survival, because TRAF32/2 addition, bothare defective inT cell functions (van Essen
et al., 1995). However, the basis for the defectivefetal liver cells are capable of long-term reconstitution
of all lineages of hematopoietic cells after transfer into T-dependent immune responses from these two muta-
tions appears tobe different. In CD402/2 mice, the B cellslethally irradiated mice. Therefore, the cell death in
TRAF32/2 mice must be secondary to physiological are intrinsically defective because the CD40 signaling
pathways are completely absent. However, in all thechanges in these mutant mice, such as the greatly in-
creased corticosteroid levels. However, TRAF3 may be parameters assayed, TRAF32/2 B cells appear to be
functionally normal. In addition, the defective T-depen-involved in the survival of B lineage precursor cells,
because a reduction of B cell precursors was detected dent immune responses in TRAF32/2 fetal liver cell–
reconstituted mice is at least partially due to defectivein the bone marrow of both TRAF32/2 mice and chimeric
mice reconstituted with TRAF32/2 fetal liver cells. T cell function. This is also different from the scenario
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Figure 5. In Vitro Responses of TRAF32/2 B Cells to Anti-IgM and mCD40L
Proliferation of small resting B cells treated with either increasing concentrations of F(ab9)2 fragment of anti-IgM antibody (A) or mCD40L (B).
Small resting B cells were purified from spleens of mice reconstituted with fetal liver cells from TRAF31/1 embryos (open circles) or TRAF32/2
embryos (closed circles). Consistent results were obtained from two independent experiments. mCD40L can induce the up-regulation of B7-1
(C) and CD23 (D) in TRAF32/2 and TRAF31/1 B cells. The genotypes are indicated in the figure; only B2201 cells are shown.
in CD402/2 mice, where impaired T cell function is a between APCs and T cells, which also require a func-
tional CD40 (Noelle, 1996).result of the disruption of CD40–CD40L interactions, as
soluble CD40 can rescue the T cell defects in CD402/2
mice (van Essen et al., 1995). Experimental Procedures
The activation of a T cell requires not only engagement
Targeting Construct to Disrupt the TRAF3 Gene in ES Cellsof the T cell receptor on the T cell surface with major
To isolate genomic DNA containing the exon of the TRAF3 genehistocompatibility complex–antigen complexes on anti-
containing the initiating ATG, we used an N-terminal 300 bp TRAF3gen-presenting cells (APCs), but also ligation of multiple
cDNA as a probe to screen a 129 genomic library (Stratagene). The
T cell coreceptors, such as CD28, through interactions exon–intron structure of the isolated genomic DNA was character-
with proteins on the surface of APCs (Janeway and Bot- ized by restriction mapping, Southern blot analysis, and DNA se-
tomly, 1994). Members of the TNF receptor family, nota- quencing. The exon containing the initiating ATGtogether with a very
small adjacent exon (totally containing 311 bp cDNA) was mapped tobly CD30 and CD27, are present on the surface of T
a 3 kb NheI restriction fragment (Figure 1A). The targeting constructcells, and their activation during T cell–APC interactions
was generated by replacing the 3 kb NheI fragment with the PGK–has been implicated in T cell activation (Ellis et al., 1993;
neor gene so that the transcriptional direction of the PGK–neor gene
McDonald et al., 1995; Hintzen et al., 1995; Meyaard et is opposite that of the TRAF3 gene (Figures 1A and 1B). Subse-
al., 1995). Since individual TRAF family members some- quently, the PGK–TK gene was inserted at one end of the homolo-
times can interact with several members of the TNF gous genomic DNA.
receptor family, for instance, TRAF2 can interact with
the cytoplasmic tails of TNFRII, CD40, and CD30 (Lee Generation of TRAF32/2 Mice
Linearized targeting construct was electroporated into J1 ES cells.et al., 1996; Gedrich et al., 1996), TRAF3 may mediate
The culture and selection of J1 ES cells were performed as pre-a signal emanating from a member of the TNF receptor
viously described (Li et al., 1992). Genomic DNA was isolated fromfamily such as CD30. In this context, disruption of TRAF3
G418/gancyclovir-resistant ES clones and assayed by Southern blot
may lead to disruption of costimulatory pathways that with EcoRI digestion and hybridization to probe A (Figure 1A).
are required for T cell activation. Alternatively, TRAF3 TRAF31/2 ES cells were injected into C57BL6/J blastocysts, and
the resulting chimeric mice were tested for germline transmissionmay be required for the efficient antigen presentation
Functional Studies of TRAF3 In Vivo
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Figure 6. T-Dependent and T-Independent Antibody Responses in Chimeric Mice Reconstituted with TRAF32/2 Fetal Liver Cells
T-dependent and T-independent antibody responses in chimeric mice reconstituted with TRAF31/1 (open squares) or TRAF32/2 (closed
squares) fetal liver cells.
(A) Impaired immune response to T-dependent antigens in TRAF32/2 fetal liver cell–reconstituted mice. Serial dilutions of serum (1:1800 initial
dilution and 3-fold dilution at each subsequent timepoint) were analyzed for NP-specific IgG. Results were presented as OD405 of anti-IgG-
specific ELISA using bovine serum albumin–NP as a capturing antigen. Consistent results were obtained from three mice of each genotype.
(B) T-independent immune response in TRAF32/2 fetal liver cell–reconstituted mice. Serial dilutions of serum (1:100 initial dilution and 3-fold
dilution at each subsequent timepoint) were analyzed for NP-specific total immunoglobulin. Consistent data were obtained from three mice
of each genotype.
Figure 7. In Vitro Responses of TRAF32/2 T Cells to Antigen and Anti-CD3e Antibody
(A) Secondary immune response of TRAF32/2 T cells to ovalbumin. At 14 days postimmunization, draining lymph node cells were recovered
from chimeric mice reconstituted with TRAF31/1 (open circles) or TRAF32/2 (closed circles) fetal liver cells and stimulated with increasing
concentrations of ovalbumin in vitro; 4 days later, cells were pulse labeled with [methyl-3H]thymidine for 12 hr. Results represent the mean
of three wells with each condition with standard deviation. Consistent results were obtained with four mice of each genotype.
(B) TRAF32/2 lymph node T cells proliferated normally in response to anti-CD3e antibody. Genotypes are indicated in the figure.
Immunity
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by backcrossing with C57BL6/J mice. Germline-transmitted F1 mice responses and at day 14 for T-dependent IgG response. Immuno-
globulin specific for NP was analyzed with a sandwich enzyme-were genotyped by Southern blot and intercrossed to generate
TRAF32/2 mice. linked immunosorbent assay (ELISA) as previously described (Sha
et al., 1995).
Affinity Purification of TRAF3 and Western Blot Analysis
In Vitro Secondary T Cell Response to Antigen
Brain, liver, and kidney of 7-day-old TRAF32/2 and TRAF31/1 lit-
At 4 months posttransplantation of fetal liver cells, chimeric mice
termates were homogenized by polytran in the immunoprecipitation
were sensitized by injection of 100 mg ovalbumin emulsified in com-
buffer (Cheng and Baltimore, 1996). Affinity purification of TRAF3
plete Freund’s adjuvant. We recovered draining lymph node 15 days
was done by incubating the same amount of total supernatant pro-
after injection and plated 2 3 105 lymph node cells into each well
teins with glutathione beads saturated with the fusion protein of
of a 96-well plate in triplicate with increasing concentrations of
glutathione S-transferase and CD40 cytoplasmic tail as described
ovalbumin. After an additional 4 days, 1 mCi of [methyl-3H]thymidine
previously (Cheng and Baltimore, 1996). The partially purified TRAF3
was added into each well, and 3H incorporation into DNA was quanti-
was displayed by electrophoresis through a 9% SDS–polyacryla-
tated by scintillation counter.
mide gel, and the Western blot was probed with polyclonal antibod-
ies against the C-terminus of TRAF3 (Santa Cruz Biotechnology).
In Vitro T Cell Response to Anti-CD3e Antibody
Single cell suspensionwas prepared from lymphnodes of the chime-
ric mice, and 105 cells were plated in one well precoated with variousWhite Cell Counts and Blood Glucose Level
To count white cells with a hematocytometer, we diluted whole concentrations of anti-CD3e antibody (Pharmingen). Each condition
was performed in triplicate. After 48 hr, T cell proliferation wasblood 1:20 in 2% acetic acid to lyse the red blood cells. To measure
the blood glucose level, whole blood was applied to the one-touch measured by [3H]thymidine incorporation as described above.
strips (Johnson & Johnson Company) and measured with a one-
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